Top Stories
Segmed's library spans more than 2800 healthcare partner sites and 150 million imaging studies.
Chai Discovery has secured AI-powered drug discovery partnerships with Novartis, Pfizer and Eli Lilly.
With the help of the PrecivityAD2 blood test results, primary care physicians were 93% accurate in diagnosing Alzheimer’s disease.
Moneta said 71% to 94% of Medicare patients improved across four measures in a model designed to reach rural neurology deserts, with therapist-rated outcomes meeting or exceeding in-person benchmarks.
The drugmaker will use Chai-3 to discover therapeutic antibodies.
Conference News
Beginning July 1, 2026, Anthem Blue Cross and Blue Shield medical policies support eligible blood-based biomarker testingNew peer-reviewed and AAIC data reinforce the clinical value of Quanterix's Luc...
ANAHEIM, Calif., July 14, 2026 /PRNewswire/ -- bioMérieux, a global leader in in vitro diagnostics, today announced it will showcase its latest diagnostic solutions and innovations at the 2026 Associa...
CLEVELAND, July 14, 2026 (GLOBE NEWSWIRE) -- Pain medicine physicians from across the U.S. will continue to expand their knowledge on the broad applications for the SPRINT PNS System at the American S...
The Consortium for Biomedical Research and Artificial Intelligence in Neurodegeneration (C-BRAIN) has launched three open-source AI tools to accelerate research into Alzheimer’s and other neurodegener...
LONDON, July 13, 2026 (GLOBE NEWSWIRE) -- The same brain training shown in the past nine months to reduce the incidence of Alzheimer’s in the ACTIVE Study and to rejuvenate the production of the brain...
